Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

XRPBitwise XRP ETF

NYSE · CIK 0002039525
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6221 Commodity Contracts Brokers & Dealers
FY end1231
XBRL facts51

Identity from submissions API

NameBitwise XRP ETF
CIK0002039525
TickersXRP
ExchangesNYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6221 Commodity Contracts Brokers & Dealers
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone415-707-3663
Website—
Investor website—
Owner org09 Crypto Assets
Flags—
Description—
Insider transactions (issuer)0
Insider transactions (owner)0

Former names

  • None listed.
Business address
250 MONTGOMERY STREET
SUITE 200
SAN FRANCISCO
CA
94104
CA
Mailing address
250 MONTGOMERY STREET
SUITE 200
SAN FRANCISCO
CA
94104
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

20 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-06 10-Q 10-Q 0001193125-26-451776 001-42963 261531692 34 3990682 1 1
2026-09-28 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003074 333-282465 261418950 33 1738
2026-09-28 424B3 PROSPECTUS 0001213900-26-104143 333-282465 261418189 33 1201821
2026-09-18 POS AM POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 0001213900-26-101333 333-282465 261390493 33 1473457
2026-08-12 10-Q 10-Q 0001193125-26-346245 001-42963 261266320 34 3930124 1 1
2026-05-08 10-Q 10-Q 0001193125-26-214111 001-42963 26957402 34 3860143 1 1
2026-03-27 424I 424I 0001193125-26-129356 333-282465 26808376 33 129991 1 1
2026-03-20 10-K 10-K 0001193125-26-117414 001-42963 26777814 34 4342017 1 1
2025-11-20 424B3 PROSPECTUS 0001213900-25-112749 333-282465 251500371 33 1147758
2025-11-20 POS EX POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001213900-25-112747 333-282465 251500365 33 312606
2025-11-19 CERT NYSE ARCA CERTIFICATION 0001143362-25-000403 001-42963 251499066 34 383689
2025-11-19 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-25-112387 001-42963 251496975 34 34853
2025-10-31 S-1/A AMENDMENT NO. 4 TO FORM S-1 0001213900-25-104765 333-282465 251441481 33 3005960
2025-10-10 CORRESP filename1.htm 0001213900-25-098174 60845
2025-10-10 S-1/A AMENDMENT NO. 3 TO FORM S-1 0001213900-25-098171 333-282465 251388634 33 1268940
2025-09-18 UPLOAD filename1.pdf 0000000000-25-010192 333-282465 51720
2025-08-22 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-25-079990 333-282465 251247181 33 1368100 1 1
2024-10-30 UPLOAD filename1.pdf 0000000000-24-012109 333-282465 42630
2024-10-16 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-24-088229 333-282465 241375414 33 1177850
2024-10-02 S-1 REGISTRATION STATEMENT 0001213900-24-084334 333-282465 241345424 33 1236215

Latest XBRL company facts

One latest value per concept from companyfacts (51 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 37.26M 2026-11-01 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
dei EntityPublicFloat Entity Public Float USD 0 2025-12-31 2025 FY 10-K 2026-03-20 0001193125-26-117414
us-gaap Assets Assets USD 615.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap AssetsHeldInTrust Assets Held-in-trust USD 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap AssetsNet Net Assets USD 614.85M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 36.99M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 36.99M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -38.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap IncreaseDecreaseInManagementAndIncentiveFeesPayable IncreaseDecreaseInManagementAndIncentiveFeesPayable USD 127,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap IncreaseDecreaseInOperatingAssets Increase (Decrease) in Operating Assets USD -38.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement USD 842,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap InvestmentCompanyExpenseOffsetArrangement Investment Company, Expense Offset Arrangement USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap InvestmentCompanyExpenseRatioExcludingIncentiveFee Investment Company, Expense Ratio Excluding Incentive Fee pure 0.003 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214111
us-gaap InvestmentCompanyExpenseRatioIncludingIncentiveFee Investment Company, Expense Ratio Including Incentive Fee pure 0.003 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap InvestmentCompanyGainLossOnInvestmentPerShare Investment Company, Gain (Loss) on Investment, Per Share USD/shares -3.8 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare Investment Company, Investment Income (Loss) from Operations, Per Share USD/shares -3.84 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap InvestmentCompanyInvestmentIncomeLossPerShare Investment Company, Investment Income (Loss), Per Share USD/shares -0.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap InvestmentCompanyInvestmentIncomeLossRatio Investment Company, Investment Income (Loss) Ratio pure -0.003 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap InvestmentCompanyTotalReturn Investment Company, Total Return pure -0.188 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap InvestmentIncomeNet Investment Income, Net USD -842,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap InvestmentOwnedAtCost Investment Owned, at Cost USD 634.88M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 615.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap InvestmentOwnedPercentOfNetAssets Investment Owned, Percent of Net Assets pure 1 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap Liabilities Liabilities USD 152,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap NetAssetValuePerShare Net Asset Value Per Share USD/shares 16.62 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 256.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -256.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -38.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap OperatingExpenses Operating Expenses USD 842,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap PartnersCapitalAccountPeriodIncreaseDecrease Increase (Decrease) in Partners' Capital USD 412.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap PartnersCapitalAccountRedemptions Partners' Capital Account, Redemptions USD 66.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap PartnersCapitalAccountSaleOfUnits Partners' Capital Account, Sale of Units USD 478.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap PartnersCapitalAccountUnitsPeriodIncreaseDecrease Partners' Capital Account, Units, Period Increase (Decrease) shares 25.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap PartnersCapitalAccountUnitsRedeemed Partners' Capital Account, Units, Redeemed shares 4.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap PartnersCapitalAccountUnitsSaleOfUnits Partners' Capital Account, Units, Sale of Units shares 29.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap PaymentsForPurchaseOfInvestmentOperatingActivity PaymentsForPurchaseOfInvestmentOperatingActivity USD 314.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 62.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap ProceedsFromDispositionOfInvestmentOperatingActivity ProceedsFromDispositionOfInvestmentOperatingActivity USD 58.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 319.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -38.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 67,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 1.489 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap SponsorFees Sponsor Fees USD 842,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 6.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451776

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →